(502d) Viscoelastic Properties and Dissolution Kinetics of Amorphous Drug Dispersion Films, Utilizing the Quartz Crystal Microbalance
AIChE Annual Meeting
Wednesday, November 1, 2017 - 9:15am to 9:40am
Carbamazepine and Copovidone were the compounds used to form amorphous drug films that were spun cast onto the QCM sensors. Solution blends in Methanol of 17% Copovidone weight by volume and Carbamazepine drug loadings of 35 to 5 mg/mL were used and spun cast. The lack of crystallinity was proven by a combination of several instrumental techniques including optical microscopy, Powder X-ray Diffraction (PXRD), and Differential Scanning Calorimetry (DSC), and the presence of Carbamazepine was shown via Fourier transform infrared spectroscopy (FTIR).
Quantitative data, including the thickness, density, and viscoelasticity, on the structural properties of the film was obtained by utilizing both the Sauerbrey and Viscoelastic models for the films. The films were found to be better modelled as soft rather than rigid, and the Sauerbrey model was not as effective. The data obtained from the Viscoelastic model was corroborated with ellipsometry to obtain a thickness. Within this body of work, the films at varying temperatures and on different surfaces to analyse their effects on the physiochemical properties of the films.
Furthermore, the dissolution kinetics of these films when submerged in water and ethanol were investigated in real time. In water, depending on the drug loading, this led to the nucleation and crystallization of the Carbamazepine in the excipient film, where the contact of the particles on the sensors are seen. The particle sizing was performed using Dynamic Light Scattering (DLS) to obtain size measurements of the Carbamazepine powder that formed.
All these works combined, showcase the strength of the QCM as a surface specific tool and its potential within the pharmaceutical formulations industry in helping to optimize the combinations of excipients and active pharmaceutical ingredients. Additionally, it offers strong insight into how the properties of the amorphous drug films change with temperature. Future studies could utilize alternative sensors and cells to further expand our knowledge and understanding of these amorphous drug films.
1. Baghel, S.; Cathcart, H.; O'Reilly, N. J. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. Journal of Pharmaceutical Sciences 2016, 105, 2527-2544.
2. Douroumis, D.; Bouropoulos, N.; Fahr, A. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method. Journal of Pharmacy and Pharmacology 2007, 59, 645-653.
3. Alonzo, D. E.; Zhang, G. G. Z.; Zhou, D.; Gao, Y.; Taylor, L. S. Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution. Pharmaceutical Research 2010, 27, 608-618.
4. Ehmann, H. M. A.; Winter, S.; Griesser, T.; Keimel, R.; Schrank, S.; Zimmer, A.; Werzer, O. Dissolution Testing of Hardly Soluble Materials by Surface Sensitive Techniques: Clotrimazole from an Insoluble Matrix. Pharmaceutical Research 2014, 31, 2708-2715.
5. Weuts, I.; Van Dycke, F.; Voorspoels, J.; De Cort, S.; Stokbroekx, S.; Leemans, R.; Brewster, M. E.; Xu, D.; Segmuller, B.; Turner, Y. T. A.; Roberts, C. J.; Davies, M. C.; Qi, S.; Craig, D. Q. M.; Reading, M. Physicochemical Properties of the Amorphous Drug, Cast Films, and Spray Dried Powders to Predict Formulation Probability of Success for Solid Dispersions: Etravirine. Journal of Pharmaceutical Sciences 2011, 100, 260-274.
6. Reviakine, I.; Johannsmann, D.; Richter, R. P. Hearing What You Cannot See and Visualizing What You Hear: Interpreting Quartz Crystal Microbalance Data from Solvated Interfaces. Analytical Chemistry 2011, 83, 8838-8848.